Bonum Therapeutics is focused on a proven technology that utilizes allosteric regulation to create targeted, highly active, and less toxic medicines.
Location: United States, Washington, Seattle
Employees: 11-50
Total raised: $93M
Founded date: 2021
Investors 2
| Date | Name | Website |
| 10.11.2023 | 3x5 Partne... | 3x5partner... |
| 23.01.2023 | Vivo Capit... | vivocapita... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 15.11.2022 | Series A | $93M | Vivo Capit... |
Mentions in press and media 4
| Date | Title | Description |
| 18.04.2023 | Protein design to precision health: Vote for Health Innovation of the Year at the GeekWire Awards | Finalists for the 2023 GeekWire Health Innovation of the Year. This year’s nominees for the Health Innovation of the Year at the GeekWire Awards showcase a wide range of innovations from companies focused on diagnostics, therapeutics, digit... |
| 15.11.2022 | Seattle biotech startup born out of a Roche buyout lands $93M to advance therapies | Seattle-based Bonum Therapeutics designs therapies that can be administered systemically for targeted activation in the body. (Good Therapeutics Graphic) Seattle biotech startup Bonum Therapeutics raised $93 million less than two months aft... |
| - | Bonum Therapeutics | “Bonum Therapeutics is focused on a proven technology that utilizes allosteric regulation to create targeted, highly active, and less toxic medicines.” |
| - | Bonum Therapeutics | “We have created a new class of antibody-regulated protein therapeutics activated only at disease sites, advancing cancer care and exploring broader indications.” |